Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - Second Study
Stopped Business decision to not continue this study (only few subjects were screened).
Conditions
- Hypoactive Sexual Desire Disorder (HSDD)
Interventions
- DRUG: Placebo Vaginal Insert
- DRUG: Prasterone 6.5 mg (0.50%) Vaginal Insert
Sponsor
EndoCeutics Inc.
Collaborators